Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Cohen Fred E
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   366,218    

Indirect Shares

   4,593,263      
Direct Value   $4,854,907    

Indirect Value

   $56,674,287      
Total Shares   4,959,481      
Total Value   $61,529,194      


Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $784,524 Caredx, Inc. $1,792,644 Intellia Therapeutics, Inc. $921,924 Urogen Pharma Ltd. $203,250 Veracyte, Inc. $209,900 Progyny, Inc. $0 Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $784,524 Caredx, Inc. $1,792,644 Intellia Therapeutics, Inc. $921,924 Urogen Pharma Ltd. $203,250 Veracyte, Inc. $209,900 Progyny, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 216.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director 2019-11-08 0 2019-11-08 0    Premium*  
            Five Prime Therapeutics Inc FPRX Director 2016-01-11 24,807 2014-07-01 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2017-09-18 119,410 2014-08-29 0    Premium*  
            Caredx, Inc. CDNA Director 2023-06-16 132,592 2014-10-01 0    Premium*  
            Intellia Therapeutics, Inc. NTLA Director 2023-06-14 41,716 2019-03-01 0    Premium*  
            Urogen Pharma Ltd. URGN Director 2019-02-06 15,000 2023-07-26 69,339    Premium*  
            Veracyte, Inc. VCYT Director 2020-10-19 10,000 2019-08-02 0    Premium*  
            Progyny, Inc. PGNY Director 2024-05-23 22,693 2020-10-24 0    Premium*  
            Kyverna Therapeutics KYTX 2024-02-12 0 2024-02-12 4,523,924    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2017-09-18 4 S $5.42 $294,035 D/D (54,250) 119,410 0 -
FPRX Five Prime Therapeutics I... Director   –       •      –    2016-01-11 4 OE $5.54 $245,294 D/D 24,695 24,807 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-12-01 4 A $5.59 $9,995 D/D 1,788 115,867 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2017-03-01 4 A $6.24 $9,996 D/D 1,602 117,469 0 -
VCYT Veracyte, Inc. Director   •       •      –    2020-10-19 4 OE $7.60 $76,000 D/D 10,000 10,000 0 -
URGN Urogen Pharma Ltd. Director   •       •      –    2023-07-26 4 A $9.54 $661,494 I/I 69,339 69,339 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-02-27 4 A $10.20 $8,741 D/D 857 102,314 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-11-30 4 A $10.61 $8,743 D/D 824 104,669 0 -
GHDX Genomic Health Inc Director   –       •      –    2012-08-01 4 OE $10.73 $88,523 D/D 8,250 59,302 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2014-11-28 4 A $10.81 $8,745 D/D 809 1,457 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-05-29 4 A $11.21 $8,744 D/D 780 103,094 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-08-31 4 A $11.64 $8,742 D/D 751 103,845 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2014-08-29 4 A $13.50 $8,748 D/D 648 648 0 -
NTLA Intellia Therapeutics, In... Director   –       •      –    2021-01-20 4 OE $13.78 $275,600 D/D 20,000 30,000 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-19 4 OE $14.37 $118,553 D/D 8,250 74,145 0 -
CDNA Caredx, Inc. Director   –       •      –    2021-01-06 4 OE $14.74 $221,100 D/D 15,000 105,893 0 -
NTLA Intellia Therapeutics, In... Director   –       •      –    2019-03-01 4 A $16.89 $168,936 D/D 10,000 10,000 0 -
URGN Urogen Pharma Ltd. Director   –       •      –    2019-02-06 4 OE $16.99 $254,850 D/D 15,000 15,000 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-18 4 OE $17.59 $297,743 D/D 16,500 82,395 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-16 4 OE $18.13 $149,573 D/D 8,250 74,145 0 -
GHDX Genomic Health Inc Director   –       •      –    2015-10-01 4 A $21.34 $9,987 D/D 468 63,844 0 -
GHDX Genomic Health Inc Director   –       •      –    2011-10-01 4 A $21.98 $9,979 D/D 454 49,903 0 -
GHDX Genomic Health Inc Director   –       •      –    2011-04-01 4 A $24.60 $9,988 D/D 406 49,091 0 -
GHDX Genomic Health Inc Director   –       •      –    2012-01-01 4 A $25.39 $9,978 D/D 393 50,427 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-04-01 4 A $25.48 $9,988 D/D 392 64,520 0 -
  117  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us